FDA NDC Directory · JSON-LD · Markdown

Deflazacort

NDC 70710-2053 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerZydus Pharmaceuticals (USA) Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA219254
Dosage form / routeTABLET · ORAL
Active ingredientsDEFLAZACORT (30 mg/1)
Marketing started20250612
Package count1

External sources

Source: openFDA. Public-domain (CC0).